Entero Healthcare Solutions Adjusts Valuation Amid Strong Financial Performance Indicators
Entero Healthcare Solutions has experienced a change in its valuation grade, influenced by key financial metrics that underscore its market position. The company has shown strong financial performance, with significant growth in net sales and operating profit, alongside a solid return on equity and low debt levels.
Entero Healthcare Solutions has recently undergone an adjustment in its evaluation, reflecting a shift in its valuation grade from very attractive to attractive. This revision is influenced by several key financial metrics that highlight the company's current market position and performance indicators.The stock's price-to-earnings (PE) ratio stands at 51.72, while the price-to-book value is recorded at 2.84. Additionally, the enterprise value to EBITDA ratio is noted at 28.98, and the enterprise value to EBIT is 35.30. The PEG ratio, which is a measure of growth relative to its earnings, is at 0.36, indicating a favorable growth outlook in relation to its valuation.
Entero Healthcare Solutions has demonstrated a robust financial performance, with net sales growing at an annual rate of 30.10% and operating profit increasing significantly by 127.38%. The company has also reported a healthy return on equity (ROE) of 5.50% and a low debt-to-equity ratio of 0.04, suggesting a solid financial foundation.
Overall, the recent evaluation adjustment reflects the company's ongoing financial health and market dynamics.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
